SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 8.77 |
Enterprise Value ($M) | 103.50 |
Book Value ($M) | 6.10 |
Book Value / Share | 3.34 |
Price / Book | 1.44 |
NCAV ($M) | 6.08 |
NCAV / Share | 3.33 |
Price / NCAV | 1.44 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -22.47 |
Return on Assets (ROA) | -5.07 |
Return on Equity (ROE) | -9.44 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.87 |
Current Ratio | 1.88 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 18.67 |
Assets | 18.69 |
Liabilities | 12.59 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D | Orbimed Advisors Llc | 19.90 | ||
13D | Viriom, Inc. | 11.60 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,509 | 9,695 | 25.88 | |
2,440 | 11,478 | 21.26 | |
9,045 | 35,014 | 25.83 | |
1,876 | 5,202 | 36.06 | |
(click for more detail) |
Similar Companies | |
---|---|
TNFA – TNF Pharmaceuticals, Inc. | TNXP – Tonix Pharmaceuticals Holding Corp. |
TPST – Tempest Therapeutics, Inc. | TTNP – Titan Pharmaceuticals, Inc. |
UNCY – Unicycive Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io